ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models.

Wang, Jingxiao; Yang, Xinjie; Han, Haibo; Wang, Limin; Bao, Weiqian; Wang, Shanshan; Hoffman, Robert M; Yang, Meng; Qi, Hui; An, Chao; Hu, Kaiwen
Chin J Cancer Res2018-2DOI: 10.21147/j.issn.1000-9604.2018.01.12
8阅读
引用收藏
分享

摘要

OBJECTIVE: Triple-negative breast cancer (TNBC) is highly invasive and metastatic, which is in urgent need of transformative therapeutics. Tubeimu (TBM), the rhizome of Bolbostemma paniculatum (Maxim.) Franquet, is one of the Chinese medicinal herbs used for breast diseases since the ancient times. The present study evaluated the efficacy, especially the anti-metastatic effects of the dichloromethane extract of Tubeimu (ETBM) on TNBC orthotopic mouse models and cell lines. METHODS: We applied real-time imaging on florescent orthotopic TNBC mice model and tested cell migration and invasion abilities with MDA-MB-231 cell line. Digital gene expression sequencing was performed and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis applied to explore the pathways influenced by ETBM. Moreover, quantitative real-time polymerase chain reactions (qRT-PCR) and Western blot were delivered to confirm the gene expression changes. RESULTS: ETBM exhibited noticeable control on tumor metastasis and growth of TNBC tumors with no obvious toxicity. In compliance with this, it also showed inhibition of cell migration and invasion in vitro. Its impact on the changed biological behavior in TNBC may be a result of decreased expression of integrin β1 (ITGβ1), integrin β8 (ITGβ8) and Rho GTPase activating protein 5 (ARHGAP5), which disabled the focal adhesion pathway and caused change in cell morphology. CONCLUSIONS: This study reveals that ETBM has anti-metastatic effects on MDA-MB-231-GFP tumor and may lead to a new therapeutic agent for the integrative treatment of highly invasive TNBC.

学科与关键词

关键词
Rho GTPase activating protein 5Traditional Chinese Medicine (TCM)Tubeimuintegrinsorthotopic mouse modelstriple negative breast cancer (TNBC)
相关
加载中…
  • Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGF? signaling pathway
    Zhang, Yuzhu; Chen, Jing; Mi, Dazhao; Ling, Jun; Li, Huachao; He, Peng; Liu, Ning; Chen, Qianjun*; Chen, Yihua*; Huang, Luqi*Cancer Letters, 2023, 560: 216142.被引 3
  • Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
    Medina, Mauricio A.*; Oza, Goldie*; Sharma, Ashutosh; Arriaga, L. G.; Hernandez Hernandez, Jose Manuel; Rotello, Vincent M.; Tapia Ramirez, JoseInternational Journal of Environmental Research and Public Health, 2020, 17(6): 2078.被引 200
  • Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
    Han, Rui*; Yang, Hongxing; Ling, Changquan; Lu, Lingeng*Cancer Cell International, 2022, 22(1): 368.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Chin J Cancer Res
发表日期
2018-02
卷期
第 30 卷, 第 1 期
页码
112-121
DOI
10.21147/j.issn.1000-9604.2018.01.12
成果收录
PUBMED

作者

  • W

    Wang, Jingxiao (第一作者)

  • Y

    Yang, Xinjie

查看全部 11 位作者收起作者
  • H

    Han, Haibo

  • W

    Wang, Limin

  • B

    Bao, Weiqian

  • W

    Wang, Shanshan

  • H

    Hoffman, Robert M

  • Y

    Yang, Meng

  • Q

    Qi, Hui

  • A

    An, Chao

  • H

    Hu, Kaiwen

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417